313 related articles for article (PubMed ID: 28874937)
1. Antimicrobial Therapy for Pneumonia in the Emergency Department: The Impact of Clinical Pharmacists on Appropriateness.
Faine BA; Mohr N; Dietrich J; Meadow L; Harland KK; Chrischilles E
West J Emerg Med; 2017 Aug; 18(5):856-863. PubMed ID: 28874937
[TBL] [Abstract][Full Text] [Related]
2. Impact of an emergency medicine pharmacist on empiric antibiotic prescribing for pneumonia and intra-abdominal infections.
Kulwicki BD; Brandt KL; Wolf LM; Weise AJ; Dumkow LE
Am J Emerg Med; 2019 May; 37(5):839-844. PubMed ID: 30097272
[TBL] [Abstract][Full Text] [Related]
3. Emergency pharmacist impact on health care-associated pneumonia empiric therapy.
DeFrates SR; Weant KA; Seamon JP; Shirakbari A; Baker SN
J Pharm Pract; 2013 Apr; 26(2):125-30. PubMed ID: 22918891
[TBL] [Abstract][Full Text] [Related]
4. Impact of emergency medicine clinical pharmacist practitioner-driven sepsis antibiotic interventions.
Hammond A; Porter R; Lynch KE; Cason TH; Passaretti P
Am J Emerg Med; 2024 Feb; 76():24-28. PubMed ID: 37979228
[TBL] [Abstract][Full Text] [Related]
5. Analysis of clinical efficacy of different initial antimicrobial treatment in healthcare associated pneumonia patients in emergency department.
Cao G; Chen X; Wu S
Chin Med J (Engl); 2014; 127(10):1814-9. PubMed ID: 24824237
[TBL] [Abstract][Full Text] [Related]
6. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
[TBL] [Abstract][Full Text] [Related]
8. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
[TBL] [Abstract][Full Text] [Related]
9. Prescribing trends and revisit rates following a pharmacist-driven protocol change for community-acquired pneumonia in an emergency department.
Zimmerman DE; Covvey JR; Nemecek BD; Guarascio AJ; Wilson L; Freedy HR; Yassin MH
Int J Pharm Pract; 2019 Jun; 27(3):279-285. PubMed ID: 30536468
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a pharmacy-driven methicillin-resistant Staphylococcus aureus surveillance protocol in pneumonia.
Dunaway S; Orwig KW; Arbogast ZQ; Myers ZL; Sizemore JA; Giancola SE
Int J Clin Pharm; 2018 Jun; 40(3):526-532. PubMed ID: 29721739
[TBL] [Abstract][Full Text] [Related]
11. Pharmacist-driven antimicrobial optimization in the emergency department.
Davis LC; Covey RB; Weston JS; Hu BB; Laine GA
Am J Health Syst Pharm; 2016 Mar; 73(5 Suppl 1):S49-56. PubMed ID: 26896526
[TBL] [Abstract][Full Text] [Related]
12. Total duration of antimicrobial therapy in veterans hospitalized with uncomplicated pneumonia: Results of a national medication utilization evaluation.
Madaras-Kelly KJ; Burk M; Caplinger C; Bohan JG; Neuhauser MM; Goetz MB; Zhang R; Cunningham FE;
J Hosp Med; 2016 Dec; 11(12):832-839. PubMed ID: 27527659
[TBL] [Abstract][Full Text] [Related]
13. Identification of 90% of patients ultimately diagnosed with community-acquired pneumonia within four hours of emergency department arrival may not be feasible.
Fee C; Weber EJ
Ann Emerg Med; 2007 May; 49(5):553-9. PubMed ID: 17210202
[TBL] [Abstract][Full Text] [Related]
14. Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia.
Simonetti A; Viasus D; Garcia-Vidal C; Adamuz J; Roset A; Manresa F; Dorca J; Gudiol F; Carratalà J
Clin Microbiol Infect; 2012 Nov; 18(11):1149-55. PubMed ID: 22115052
[TBL] [Abstract][Full Text] [Related]
15. Emergency medicine pharmacists and sepsis management.
Weant KA; Baker SN
J Pharm Pract; 2013 Aug; 26(4):401-5. PubMed ID: 23204144
[TBL] [Abstract][Full Text] [Related]
16. Impact of a Pediatric Emergency Medicine Pharmacist, Institutional Guideline, and Electronic Order Set on Empiric Antimicrobial Use for Febrile Neutropenia.
Aluisio YM; Sanchez AC; Norris KR; Waller J; Campbell CT
Pediatr Emerg Care; 2024 Feb; 40(2):151-155. PubMed ID: 37440312
[TBL] [Abstract][Full Text] [Related]
17. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.
Grenier C; Pépin J; Nault V; Howson J; Fournier X; Poirier MS; Cabana J; Craig C; Beaudoin M; Valiquette L
J Antimicrob Chemother; 2011 Jul; 66(7):1617-24. PubMed ID: 21586592
[TBL] [Abstract][Full Text] [Related]
18. Mortality in healthcare-associated pneumonia in a low resistance setting: a prospective observational study.
Bjarnason A; Asgeirsson H; Baldursson O; Kristinsson KG; Gottfredsson M
Infect Dis (Lond); 2015 Mar; 47(3):130-6. PubMed ID: 25664503
[TBL] [Abstract][Full Text] [Related]
19. Impact of atypical coverage for patients with community-acquired pneumonia managed on the medical ward: results from the United States Community-Acquired Pneumonia Project.
Frei CR; Koeller JM; Burgess DS; Talbert RL; Johnsrud MT
Pharmacotherapy; 2003 Sep; 23(9):1167-74. PubMed ID: 14524648
[TBL] [Abstract][Full Text] [Related]
20. Treatment Trends and Outcomes in Healthcare-Associated Pneumonia.
Haessler S; Lagu T; Lindenauer PK; Skiest DJ; Priya A; Pekow PS; Zilberberg MD; Higgins TL; Rothberg MB
J Hosp Med; 2017 Nov; 12(11):886-891. PubMed ID: 29091975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
